Phytobezoar Associated with Levodopa-carbidopa Intestinal Gel Infusion in Patients with Parkinson's Disease: A Case Report and Literature Review

被引:2
|
作者
Ueno, Tatsuya [1 ]
Hanabata, Norihiro [2 ]
Katagai, Atsuko [1 ]
Okudera, Rena [1 ,3 ]
Arai, Akira [1 ]
Tomiyama, Masahiko [4 ]
机构
[1] Aomori Prefectural Cent Hosp, Dept Neurol, Aomori, Japan
[2] Aomori Prefectural Cent Hosp, Dept Gastroenterol, Aomori, Japan
[3] Natl Def Med Coll, Dept Internal Med, Div Neurol, Tokorozawa, Saitama, Japan
[4] Hirosaki Univ, Dept Neurol, Grad Sch Med, Hirosaki, Aomori, Japan
关键词
levodopa-carbidopa intestinal gel; parkinson's disease; phytobezoar; device-aided therapy; J-tube; gastrointestinal symptom; COMPLICATION;
D O I
10.2169/internalmedicine.7210-21
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel (LCIG) is an established device-aided therapy for advanced Parkinson's disease (PD). Phytobezoar associated with LCIG is a rare device-related complication and presents with exacerbations of gastrointestinal and PD symptoms. We herein report the case of a phytobezoar that was formed at a knot on the pigtail-shaped J-tube and developed only in association with postprandial abdominal pain, similar to a feeling of a tube being pulled in without an exacerbation of PD symptoms. Such abdominal pain may be a warning sign of phytobezoar in LCIG-treated patients. Despite device-related complications, high-pressure alarms are not always present, and PD symptoms are not always exacerbated.
引用
收藏
页码:3317 / 3320
页数:4
相关论文
共 50 条
  • [1] Continuous infusion of levodopa-carbidopa intestinal gel in Parkinson's disease
    Guthikonda, Lalitha N.
    Lyons, Kelly E.
    Pahwa, Rajesh
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2014, 3 (04) : 331 - 333
  • [2] Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review
    Wirdefeldt, Karin
    Odin, Per
    Nyholm, Dag
    CNS DRUGS, 2016, 30 (05) : 381 - 404
  • [3] Weight variation in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion
    Fernandez-Rodriguez, B.
    Dupouy, J.
    Harroch, E.
    Fabre-Delcros, M. H.
    Barthelemy, C.
    Loubiere, P.
    Barange, K.
    Brefel-Courbon, C.
    Rascol, O.
    Ory-Magne, F.
    MOVEMENT DISORDERS, 2018, 33 : S137 - S137
  • [4] Comment on: “Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson’s Disease: A Systematic Review”
    Andrew T. Lambarth
    CNS Drugs, 2016, 30 : 1007 - 1008
  • [5] Comment on: "Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review"
    Lambarth, Andrew T.
    CNS DRUGS, 2016, 30 (10) : 1007 - 1008
  • [6] The pharmacokinetics of patients with Parkinson's disease receiving levodopa-carbidopa intestinal gel infusion therapy
    Mukai, Y.
    Miyazaki, M.
    Mukai, T.
    Tasaki, A.
    Yuji, T.
    Murata, M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 586 - 586
  • [7] Levodopa-carbidopa intestinal gel for advanced Parkinson's disease
    Bohlega S
    Abou Al-Shaar H
    Alkhairallah T
    中华物理医学与康复杂志, 2016, (03) : 179 - 179
  • [8] Management of chronic polyneuropathy associated with levodopa-carbidopa intestinal gel infusion in Parkinson's disease: Review of the strategies and perspectives
    Cransac, C.
    Dupouy, J.
    Loubiere, P.
    Ackett, B.
    Cintas, P.
    Courbon, C. Brefel
    Rascol, O.
    Magne, F. Ory
    MOVEMENT DISORDERS, 2018, 33 : S142 - S142
  • [9] Suicide in Parkinson's Disease Patients Treated With Levodopa-Carbidopa Intestinal Gel
    Zorko, Nika
    Kojovic, Maja
    Flisar, Dusan
    Pirtosek, Zvezdan
    Kramberger, Milica Gregoric
    MOVEMENT DISORDERS, 2015, 30 (10) : 1434 - 1435
  • [10] Efficacy of levodopa-carbidopa intestinal GEL infusion on advanced Parkinson's disease patients at our hospital
    Sakata, M.
    Hiwatani, Y.
    Matsumoto, T.
    Minamino, M.
    Hironishi, M.
    Ito, H.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 728 - 728